TITLE:
Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.

CONDITION:
Colorectal Neoplasms

INTERVENTION:
SU011248

SUMMARY:

      Assessment of safety and efficacy of SU11248 in patients with metastatic colorectal cancer
      who have failed selected previous treatments.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Metastatic colorectal cancer

          -  Failed selected cancer therapies in the past.

        Exclusion Criteria:

          -  Prior treatment with tyrosine kinase inhibitors or VEGF inhibitors other than
             bevacizumab.
      
